208 related articles for article (PubMed ID: 29742177)
1. Increased α-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
Kovac B; Mäkelä TP; Vallenius T
PLoS One; 2018; 13(5):e0196986. PubMed ID: 29742177
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model.
Ribeiro AS; Sousa B; Carreto L; Mendes N; Nobre AR; Ricardo S; Albergaria A; Cameselle-Teijeiro JF; Gerhard R; Söderberg O; Seruca R; Santos MA; Schmitt F; Paredes J
J Pathol; 2013 Apr; 229(5):705-18. PubMed ID: 23180380
[TBL] [Abstract][Full Text] [Related]
3. Sal-like 4 (SALL4) suppresses CDH1 expression and maintains cell dispersion in basal-like breast cancer.
Itou J; Matsumoto Y; Yoshikawa K; Toi M
FEBS Lett; 2013 Sep; 587(18):3115-21. PubMed ID: 23954296
[TBL] [Abstract][Full Text] [Related]
4. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
[TBL] [Abstract][Full Text] [Related]
5. Regulation of local expression of cell adhesion and motility-related mRNAs in breast cancer cells by IMP1/ZBP1.
Gu W; Katz Z; Wu B; Park HY; Li D; Lin S; Wells AL; Singer RH
J Cell Sci; 2012 Jan; 125(Pt 1):81-91. PubMed ID: 22266909
[TBL] [Abstract][Full Text] [Related]
6. E-cadherin binding modulates EGF receptor activation.
Fedor-Chaiken M; Hein PW; Stewart JC; Brackenbury R; Kinch MS
Cell Commun Adhes; 2003; 10(2):105-18. PubMed ID: 14681060
[TBL] [Abstract][Full Text] [Related]
7. FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.
Michaud JL; Chaisson KM; Parks RJ; Kennedy CR
Kidney Int; 2006 Sep; 70(6):1054-61. PubMed ID: 16837921
[TBL] [Abstract][Full Text] [Related]
8. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
9. Targeted Pten deletion plus p53-R270H mutation in mouse mammary epithelium induces aggressive claudin-low and basal-like breast cancer.
Wang S; Liu JC; Kim D; Datti A; Zacksenhaus E
Breast Cancer Res; 2016 Jan; 18(1):9. PubMed ID: 26781438
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
11. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
Hollestelle A; Elstrodt F; Timmermans M; Sieuwerts AM; Klijn JG; Foekens JA; den Bakker MA; Schutte M
Breast Cancer Res Treat; 2010 Jul; 122(1):125-33. PubMed ID: 19763817
[TBL] [Abstract][Full Text] [Related]
12. Claudin 1 Expression Levels Affect miRNA Dynamics in Human Basal-Like Breast Cancer Cells.
Majer A; Blanchard AA; Medina S; Booth SA; Myal Y
DNA Cell Biol; 2016 Jul; 35(7):328-39. PubMed ID: 26982264
[TBL] [Abstract][Full Text] [Related]
13. P-cadherin role in normal breast development and cancer.
Albergaria A; Ribeiro AS; Vieira AF; Sousa B; Nobre AR; Seruca R; Schmitt F; Paredes J
Int J Dev Biol; 2011; 55(7-9):811-22. PubMed ID: 22161837
[TBL] [Abstract][Full Text] [Related]
14. Expression analysis of epithelial cadherin and related proteins in IBH-6 and IBH-4 human breast cancer cell lines.
Lapyckyj L; Castillo LF; Matos ML; Gabrielli NM; Lüthy IA; Vazquez-Levin MH
J Cell Physiol; 2010 Mar; 222(3):596-605. PubMed ID: 19957299
[TBL] [Abstract][Full Text] [Related]
15. ERβ1 inhibits the migration and invasion of breast cancer cells through upregulation of E-cadherin in a Id1-dependent manner.
Zhou Y; Ming J; Xu Y; Zhang Y; Jiang J
Biochem Biophys Res Commun; 2015 Feb; 457(2):141-7. PubMed ID: 25514034
[TBL] [Abstract][Full Text] [Related]
16. Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells.
Shankar J; Nabi IR
PLoS One; 2015; 10(3):e0119954. PubMed ID: 25756282
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Cell-Like Elasticity Modulates Actin-Dependent E-Cadherin Adhesion Organization.
Eftekharjoo M; Mezher M; Chatterji S; Maruthamuthu V
ACS Biomater Sci Eng; 2022 Jun; 8(6):2455-2462. PubMed ID: 35549026
[TBL] [Abstract][Full Text] [Related]
18. Glypican-3 induces a mesenchymal to epithelial transition in human breast cancer cells.
Castillo LF; Tascón R; Lago Huvelle MR; Novack G; Llorens MC; Dos Santos AF; Shortrede J; Cabanillas AM; Bal de Kier Joffé E; Labriola L; Peters MG
Oncotarget; 2016 Sep; 7(37):60133-60154. PubMed ID: 27507057
[TBL] [Abstract][Full Text] [Related]
19. E-cadherin regulates the association between beta-catenin and actinin-4.
Hayashida Y; Honda K; Idogawa M; Ino Y; Ono M; Tsuchida A; Aoki T; Hirohashi S; Yamada T
Cancer Res; 2005 Oct; 65(19):8836-45. PubMed ID: 16204054
[TBL] [Abstract][Full Text] [Related]
20. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
